Open Development and Clinical Validation of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck
Open Access
- 1 August 2020
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 58 (8)
- https://doi.org/10.1128/JCM.00876-20
Abstract
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a severe international shortage of the nasopharyngeal swabs that are required for collection of optimal specimens, creating a critical bottleneck blocking clinical laboratories' ability to perform high-sensitivity virological testing for SARS-CoV-2. To address this crisis, we designed and executed an innovative, cooperative, rapid-response translational-research program that brought together health care workers, manufacturers, and scientists to emergently develop and clinically validate new swabs for immediate mass production by 3D printing. We performed a multistep preclinical evaluation of 160 swab designs and 48 materials from 24 companies, laboratories, and individuals, and we shared results and other feed- back via a public data repository (http://github.com/rarnaout/Covidswab/). We validated four prototypes through an institutional review board (IRB)-approved clinical trial that involved 276 outpatient volunteers who presented to our hospital's drive-through testing center with symptoms suspicious for COVID-19. Each participant was swabbed with a reference swab (the control) and a prototype, and SARS-CoV-2 reverse transcriptase PCR (RT-PCR) results were compared. All prototypes displayed excellent concordance with the control (kappa = 0.85 to 0.89). Cycle threshold (C-T) values were not significantly different between each prototype and the control, supporting the new swabs' noninferiority (Mann-Whitney U [MWU] test, P> 0.05). Study staff preferred one of the prototypes over the others and preferred the control swab overall. The total time elapsed between identification of the problem and validation of the first prototype was 22 days. Contact information for ordering can be found at http://printedswabs.org . Our experience holds lessons for the rapid development, validation, and deployment of new technology for this pandemic and beyond.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (T32AI007061)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (F32AI124590)
- HHS | NIH | National Center for Advancing Translational Sciences (UL 1TR002541)
This publication has 12 references indexed in Scilit:
- Nasal Swab Sampling for SARS-CoV-2: a Convenient Alternative in Times of Nasopharyngeal Swab ShortageJournal of Clinical Microbiology, 2020
- Saliva is a reliable tool to detect SARS-CoV-2Journal of Infection, 2020
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected PatientsNew England Journal of Medicine, 2020
- Use of Crowd Innovation to Develop an Artificial Intelligence–Based Solution for Radiation Therapy TargetingJAMA Oncology, 2019
- 3D-printing techniques in a medical setting: a systematic literature reviewBioMedical Engineering OnLine, 2016
- The Effect of Organizational Structure on Open Innovation: A Quadratic EquationProcedia Computer Science, 2016
- Changing Swabs: To Validate or Not To Validate?Journal of Clinical Microbiology, 2013
- Prize-based contests can provide solutions to computational biology problemsNature Biotechnology, 2013
- Inhibitory effect of common microfluidic materials on PCR outcomeSensors and Actuators B: Chemical, 2012
- Concordance AnalysisDeutsches Ärzteblatt international, 2011